Nitrate (NO3−), one of the most important inorganic aerosols in the atmosphere, is mainly formed by oxidation of NOx by the hydroxyl radical (OH) and ozone (O3) in urban atmospheres. However, the fractional contributions of its various oxidation pathways remain unclear. Here, we collected particulate matter with aerodynamic diameter less than 2.5 μm (PM2.5) samples in a second‐tier city in southeast China from 1 September to 31 December 2017 and measured the NO3− and nitrate isotopic compositions (δ15N and δ18O). The average concentration of NO3−, δ15N, and δ18O values were 14.7 ± 11.6 μg/m3, (+4.3 ± 4.3)‰, and (+71.8 ± 14.7)‰ with the ranges from 0.8 to 57.7 μg/m3, −10.5‰ to +12.5‰ and +34.5‰ to +91.9‰, respectively. All three species were significantly higher in winter than in summer. Based on a Bayesian mixing model with a dual isotope array for NO3−, contributions of (37.1 ± 33.4)%, (60.3 ± 32.2)%, and (2.6 ± 2.7)% to NO3− could be attributed to OH oxidation, N2O5 hydrolysis, and NO3 + hydrocarbon (HC) pathways, respectively. Higher OH radical concentrations with higher ratios of OH to O3 led to lower NO3− concentrations, while lower OH radical concentrations with higher ratios of O3 to OH led to higher contributions of N2O5 hydrolysis, forming higher NO3− concentrations in winter. Under low OH, an increased O3 to NOx ratio increased the contribution of the NO3 + HC pathway. The comprehensive analysis of the isotopic compositions of nitrate helped identify the importance of major oxidation pathways of NOx in this city.
The problem of exponential stabilization for nonholonomic mobile robot with dependent stochastic disturbance of heading angle is considered in this paper. An integrator backstepping controller based on state-scaling method is designed such that the state of the closed-loop system, starting from a nonzero initial heading angle, is regulated to the origin with exponential rate in almost surely sense. For zero initial heading angle, a controller is designed such that the heading angle is driven away from zero while the position variables are bounded in a neighborhood of the origin. Combing the above two cases results in a switching controller such that for any initial condition the configuration of the robot can be regulated to the origin with exponential rate. The efficiency of the proposed method is demonstrated by a detailed simulation.
Background Human CD133+ hematopoietic progenitor cells (HPCs) are a specific subset of cells that can regulate tumor malignancy. However, the mechanism by which CD133+ HPCs affect the malignancy of human breast cancer has not been reported. Methods CD133+ HPCs were isolated and purified from human umbilical cord blood (UCB). We used in vitro culture of MCF-7 and MDA-MB-231 cell lines, and MCF-7 and MDA-MB-231 cells in nude mice to evaluate whether CD133+ HPCs affected the apoptosis, proliferation, invasion and epithelial mesenchymal transition EMT of breast cancer cells. Results Co-culture with CD133+ HPCs, but not UCB CD133- cells, promoted the proliferation of human breast cancer MCF-7 and MDA-MB-231 cells, accompanied by reducing in vitro spontaneous apoptosis. Co-administration of these two lines with CD133+ HPCs significantly enhanced the growth of implanted breast cancer in vivo. Furthermore, co-culture with CD133+ HPCs, enhanced the invasion of breast cancer cells, N-cadherin and Vimentin expression, but reduced E-cadherin expression in breast cancer cells. Conclusions Our study demonstrated that CD133+ HPCs enhance the malignancy of breast cancer cells by attenuating spontaneous apoptosis and promoting the process of epithelial mesenchymal transition. These findings may provide new insights into the role of human CD133+ HPCs in breast cancer pathogenesis. Therefore, CD133+ HPCs may be a new therapeutic target for inhibiting the progression of breast cancer.
With social progress and technological development, especially the applications of analysis of structural material ,structural system, and construction scheme ,high-rise buildings are becoming higher, lighter and more flexible.Therefore, the paper aims to make designs in accordance with requested comfort sensation, by providing practical measures.Judging standards adopted in this paper is top maximum acceleration, along with variation trend derived from analysing comfort sensation difference between cross-wind and along-wind acceleration.
Background: Human CD133+ hematopoietic progenitor cells (HPCs) are a specific subset of cells that can regulate tumor malignancy. However, the mechanism by which CD133+ HPCs affect the malignancy of human breast cancer has not been reported. Methods: CD133+ HPCs were isolated and purified from human umbilical cord blood (UCB) .We used in vitro culture of MCF-7 and MDA-MB-231 cell lines, and MCF-7 and MDA-MB-231 cells in nude mice to evaluate whether CD133+ HPCs affected the apoptosis, proliferation, invasion and epithelial mesenchymal transition EMT of breast cancer cells. Results: Co-culture with CD133+ HPCs, but not UCB CD133- cells, promoted the proliferation of human breast cancer MCF-7 and MDA-MB-231 cells, accompanied by reducing in vitro spontaneous apoptosis. Co-administration of these two lines with CD133+ HPCs significantly enhanced the growth of implanted breast cancer in vivo. Furthermore, co-culture with CD133+ HPCs, enhanced the invasion of breast cancer cells, N-cadherin and Vimentin expression, but reduced E-cadherin expression in breast cancer cells. Conclusions: Our study demonstrated that CD133+ HPCs enhance the malignancy of breast cancer cells by attenuating spontaneous apoptosis and promoting the process of epithelial mesenchymal transition. These findings may provide new insights into the role of human CD133+ HPCs in breast cancer pathogenesis. Therefore, CD133+ HPCs may be a new therapeutic target for inhibiting the progression of breast cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.